Chronic inflammatory demyelinating polyradiculopathy as a paraneoplastic manifestation of metastatic melanoma

Authors

  • Deep K. Patel, MD Neuromuscular Center, Cleveland Clinic
  • Yuebing Li, MD, PhD Neuromuscular Center, Cleveland Clinic
  • Yonatan Spolter, MD Neuromuscular Center, Cleveland Clinic
  • James Isaacs, MD Department of Hematology and Medical Oncology, Cleveland Clinic
  • Samer Naffouje, MD Department of General Surgery, Cleveland Clinic

DOI:

https://doi.org/10.17161/rrnmf.v5i3.21857

Keywords:

Chronic inflammatory demyelinating polyneuropathy, paraneoplastic, metastatic melanoma

Abstract

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disease that leads to proximal greater than distal weakness. It follows a relapsing course and requires treatment with chronic immune suppressing therapy such as steroids or intravenous immunoglobulin infusions. The vast majority of cases are idiopathic. However, there has been an established association with malignancy. Hematologic malignancies are the most commonly associated, but solid tumors are implicated as well. CIDP associated with melanoma has been reported in several previous case reports. Despite these reports, this association is not widely known. We report a case of a patient with a remote history of resected melanoma who developed severe refractory CIDP. He was found to have a recurrent metastatic melanoma. He experienced sustained clinical improvement with treatment of both the CIDP and malignancy. We then compare the characteristics of this case with others reported in the literature. This case along with other reports highlights the importance of being aware of this association and emphasizes that treatment of both the neuropathy and malignancy leads to maximal clinical effect. 

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

References

Allen JA, Lewis RA. Diagnosis of chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2022 Nov;66(5):545-551. doi: 10.1002/mus.27708. Epub 2022 Sep 6. PMID: 36259623.’

Rajabally YA, Attarian S. Chronic inflammatory demyelinating polyneuropathy and malignancy: A systematic review. Muscle Nerve. 2018 Jun;57(6):875-883. doi: 10.1002/mus.26028. Epub 2017 Dec 20. PMID: 29194677.

Bird SJ, Brown MJ, Shy ME, Scherer SS. Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma. Neurology. 1996 Mar;46(3):822-4. doi: 10.1212/wnl.46.3.822. PMID: 8618691.

Weiss MD, Luciano CA, Semino-Mora C, Dalakas MC, Quarles RH. Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma. Neurology. 1998 Dec;51(6):1738-41. doi: 10.1212/wnl.51.6.1738. PMID: 9855537.

Antoine JC, Mosnier JF, Absi L, Convers P, Honnorat J, Michel D. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies. J Neurol Neurosurg Psychiatry. 1999 Jul;67(1):7-14. doi: 10.1136/jnnp.67.1.7. PMID: 10369814; PMCID: PMC1736440.

Kloos L, Sillevis Smitt P, Ang CW, Kruit W, Stoter G. Paraneoplastic ophthalmoplegia and subacute motor axonal neuropathy associated with anti-GQ1b antibodies in a patient with malignant melanoma. J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):507-9. doi: 10.1136/jnnp.74.4.507. PMID: 12640075; PMCID: PMC1738398.

Rousseau A, Salachas F, Baccard M, Delattre JY, Sanson M. Chronic inflammatory polyneuropathy revealing malignant melanoma. J Neurooncol. 2005 Feb;71(3):335-6. doi: 10.1007/s11060-004-1871-3. PMID: 15735927.

Palma JA, Martín-Algarra S. Chronic inflammatory demyelinating polyneuropathy associated with metastatic malignant melanoma of unknown primary origin. J Neurooncol. 2009 Sep;94(2):279-81. doi: 10.1007/s11060-009-9848-x. Epub 2009 Mar 6. PMID: 19266164.

Dbouk, M. B., Nafissi, S., & Ghorbani, A. (2012). Chronic inflammatory demyelinating polyneuropathy following malignant melanoma. Neurosciences (Riyadh, Saudi Arabia), 17(2), 167–170.

Chau AM, Yu A, Keezer MR. Chronic inflammatory demyelinating polyneuropathy and metastatic melanoma. Can J Neurol Sci. 2013 Sep;40(5):750-2. doi: 10.1017/s0317167100015080. PMID: 23968958.

Dubey D, David WS, Amato AA, Reynolds KL, Clement NF, Chute DF, Cohen JV, Lawrence DP, Mooradian MJ, Sullivan RJ, Guidon AC. Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies. Neurology. 2019 Sep 10;93(11):e1093-e1103. doi: 10.1212/WNL.0000000000008091. Epub 2019 Aug 12. PMID: 31405908.

Graus F, Dalmau J. Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nat Rev Clin Oncol. 2019 Sep;16(9):535-548. doi: 10.1038/s41571-019-0194-4. PMID: 30867573.

Downloads

Published

2024-12-17

Issue

Section

Clinic and Case Reports

How to Cite

Patel, D., Li, Y., Spolter, Y., Isaacs, J., & Naffouje, S. (2024). Chronic inflammatory demyelinating polyradiculopathy as a paraneoplastic manifestation of metastatic melanoma. RRNMF Neuromuscular Journal, 5(3). https://doi.org/10.17161/rrnmf.v5i3.21857